<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

DNA

Research    DNA    Awards

Karolin Luger, PhD, Honored By World Laureates Association

University of Colorado Cancer Center member Karolin Luger, PhD, a distinguished professor of biochemistry at CU Boulder, has been awarded the 2023 World Laureates Association (WLA) Prize in Life Science or Medicine.


Author Greg Glasgow | Publish Date October 13, 2023
Full Story

Research    Breast Cancer    DNA   

Researchers Find Less Risky Way to Monitor Breast Cancer Progression

Researchers at the University of Colorado Anschutz Medical Campus have discovered how to extract critical information about breast cancer tumors and disease progression by analyzing blood plasma rather than using more invasive tissue biopsies.

“This is simply a blood draw,” said the study’s senior co-author Peter Kabos, MD, associate professor of medicine in the medical oncology division at the University of Colorado School of Medicine and CU Cancer Center member. “This allows us to look under the surface to see the defining characteristics of the disease. The advantage is that we don’t need to do repeated tissue biopsies.”


Author David Kelly | Publish Date August 25, 2022
Full Story

Cancer    DNA    Irinotecan    AZD0156

Irinotecan breaks cancer cell DNA – AZD0156 keeps the body from repairing it

The chemotherapy drug irinotecan creates DNA damage leading to cell death and is used to treat colorectal cancer, among other cancer types. Now a University of Colorado Cancer Center study presented at the American Association for Cancer Research (AACR) Annual Meeting 2019 suggests a way to make irinotecan work even better: When researchers added the experimental drug AZD0156 to irinotecan, colorectal cancer cells and models of human colorectal cancer tumors grown in mice both showed significantly more cancer cell inhibition than with irinotecan used alone. An ongoing phase 1 clinical trial is currently testing the combination against advanced solid tumors (NCT02588105).


Author Cancer Center | Publish Date April 03, 2019
Full Story

CU Cancer Center In the News

Mile High Magazine

Mile High Magazine - March is Colorectal Awareness Month

news outletMile High Magazine
Publish DateFebruary 25, 2024

Christopher Lieu, MD speaks on March being Colorectal Cancer Awareness Month and the importance of screening.

Full Story
National Institutes of Health (NIH)

NIH research network to evaluate emerging cancer screening technologies

news outletNational Institutes of Health (NIH)
Publish DateFebruary 21, 2024

In 2024, the network will launch a pilot study, known as the Vanguard Study on Multi-Cancer Detection, to address the feasibility of using multi-cancer detection (MCD) tests in future randomized controlled trials.

Full Story
MHealthIntelligence

Leveraging RPM to Enable At-Home Care for High-Risk Cancer Patients

news outletMHealthIntelligence
Publish DateFebruary 05, 2024

Glen Peterson, DNP, ACNP, RN, from CU Cancer Center, discusses RPM & telehealth benefits for cancer patients on Healthcare Strategies podcast.

Full Story
9News

Sunday is World Cancer Day

news outlet9News
Publish DateFebruary 04, 2024

CU Anschutz oncologist and CU Cancer Center member Dr. Wells Messersmith shares insights: Colorado braces for over 29,000 cancer cases in the coming year.

Full Story